Repurposing quinacrine for treatment-refractory cancer.

Oien, Derek B; Pathoulas, Christopher L; Ray, Upasana; Thirusangu, Prabhu; Kalogera, Eleftheria; Shridhar, Viji

Oien, Derek B; Pathoulas, Christopher L; Ray, Upasana; Thirusangu, Prabhu; Kalogera, Eleftheria; Shridhar, Viji.

Afiliação

Oien DB; Division of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, United States.
Pathoulas CL; Division of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, United States.
Ray U; Division of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, United States.
Thirusangu P; Division of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, United States.
Kalogera E; Division of Gynecologic Surgery, Mayo Clinic, Rochester, MN, United States.
Shridhar V; Division of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, United States. Electronic address: shridhar.vijayalakshmi@mayo.edu.

Semin Cancer Biol ; 68: 21-30, 2021 01.

Article em En | MEDLINE | ID: mdl-31562955

Assuntos

Antimaláricos/uso terapêutico; Antineoplásicos/uso terapêutico; Descoberta de Drogas; Reposicionamento de Medicamentos/métodos; Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos; Neoplasias/tratamento farmacológico; Quinacrina/uso terapêutico; Animais; Humanos

Palavras-chave

Breast cancer; Drug repurposing; Endometrial cancer; Ovarian cancer; Quinacrine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinacrina / Resistencia a Medicamentos Antineoplásicos / Descoberta de Drogas / Reposicionamento de Medicamentos / Neoplasias / Antimaláricos / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Semin Cancer Biol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google